Alembic Pharmaceuticals
Highly Engaged Employees
Manufacturing · India · 10K+ Employees
View Company Info for Free
Overview
Headquarters
Alembic Rd, Gorwa, Gujarat, 390003, Indi...Phone Number
+91 2656637000Revenue
$742.9 MillionStock Symbol
533573Industry
About Alembic Pharmaceuticals
Alembic Pharmaceuticals Org Chart
Is Alembic Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Alembic Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Alembic Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Alembic Pharmaceuticals recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if Alembic Pharmaceuticals is spiking on competitors!
Click to see if Alembic Pharmaceuticals had a recent Job posting/layoffs
Product Launch: Get notified when Alembic Pharmaceuticals launches new products
Funding: Get notified immidiatlly once Alembic Pharmaceuticals has new funding data
Congratulate Masked Content for being promoted to Masked Content at Alembic Pharmaceuticals
Recommended Actions
Reach out to Masked Content who joined Alembic Pharmaceuticals as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Alembic Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Alembic Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Alembic Pharmaceuticals.
Alembic Pharmaceuticals Tech Stack
A closer look at the technologies used by Alembic Pharmaceuticals
Most Recent Scoops
Alembic Pharmaceuticals News & Media
Alembic Pharmaceuticals Secures USFDA Approval for Dexlansoprazole Capsules ... - ScanX
Alembic Pharmaceuticals has received final approval from the USFDA for Dexlansoprazole Delayed-Release Capsules in 30 mg and 60 mg strengths. The product, equivalent to Takeda's Dexilant, is used for treating gastrointestinal conditions in patients 12 years and older. With an estimated market size of $285 million, this approval marks Alembic's 209th final USFDA approval, bringing their total ANDA approvals to 229.Life Insurance Corporation of India Holds 4.32 Per Cent Stake: Leading Pharma company ...
Alembic Pharmaceuticals Limited has announced the commissioning of a new manufacturing facility located at Pithampur, District Dhar, Madhya Pradesh. The announcement was made on April 26, 2025, in...Alembic Pharmaceuticals Joins PM's Internship Scheme to Boost Youth Employment
Alembic Pharmaceuticals Limited announces its participation in the Prime Minister's internship scheme aimed at providing internship opportunities for one crore young Indians across top companies. Explore the details of available positions and how to apply.Alembic intros generic Alphagan P ophthalmic solution
Brimonidine Tartrate 0.15% is an alpha-adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Top Manufacturing Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Alembic Pharmaceuticals
Founded in 1907 and headquartered in Vadodara, India, Alembic Limited is an integrated pharmaceutical company. The Company's products include active pharmaceutical ingredients, bulk pharmaceuticals, international and domestic formulations, herbals and nutraceuticals, and veterinary.... Read More